Gender differences in cognitive function of patients with chronic schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 39, Issue 2, 2012, Pages 358-363

  Han, Mei ^a,b   Huang, Xu Feng ^a,b   Chen, Da Chun ^c   Xiu, Mei Hong ^c   Hui, Li ^c   Liu, Haibo ^c   Kosten, Thomas R ^c,d   Zhang, Xiang Yang ^c,d  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

^c PEKING UNIVERSITY   (China)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cognitive deficits; Correlation; Gender difference; PANSS; RBANS; Schizophrenia

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; HALOPERIDOL; PERPHENAZINE; RISPERIDONE; SULPIRIDE;

ADULT; AGED; ARTICLE; ATTENTION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPTH PERCEPTION; DISEASE DURATION; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; HUMAN; LANGUAGE ABILITY; MAJOR CLINICAL STUDY; MALE; MEMORY CONSOLIDATION; MENTAL PERFORMANCE; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; SCORING SYSTEM; SEX DIFFERENCE;

CASE-CONTROL STUDIES; CHRONIC DISEASE; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; REPRESSION, PSYCHOLOGY; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEX CHARACTERISTICS;

EID: 84867013299     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2012.07.010     Document Type: Article

References (45)

1. Abe Y., Namba H., Zheng Y., Nawa H. In situ hybridization reveals developmental regulation of ErbB1-4 mRNA expression in mouse midbrain: implication of ErbB receptors for dopaminergic neurons. Neuroscience 2009, 161:95-110.
2. Antonova E., Sharma T., Morris R., Kumari V. The relationship between brain structure and neurocognition in schizophrenia: a selective review. Schizophr Res 2004, 70:117-145.
3. Crook J.M., Tomaskovic-Crook E., Copolov D.L., Dean B. Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation. Biol Psychiatry 2000, 48:381-388.
4. Daban C., Amado I., Bourdel M.-C., Loo H., Olie J.-P., Poirier M.-F., et al. Cognitive dysfunctions in medicated and unmedicated patients with recent-onset schizophrenia. J Psychiatr Res 2005, 39:391-398.
5. DeLisi L.E., Stritzke P.H., Holan V., Anand A., Boccio A., Kuschner M., et al. Brain morphological changes in 1st episode cases of schizophrenia: are they progressive?. Schizophr Res 1991, 5:206-208.
6. Deng C., Huang X.-F. Decreased density of muscarinic receptors in the superior temporal gyrusin schizophrenia. J Neurosci Res 2005, 81:883-890.
7. Di Paolo T. Modulation of brain dopamine transmission by sex steroids. Rev Neurosci 1994, 5:27-41.
8. Duff K., Humphreys Clark J.D., O'Bryant S.E., Mold J.W., Schiffer R.B., Sutker P.B. Utility of the RBANS in detecting cognitive impairment associated with Alzheimer's disease: sensitivity, specificity, and positive and negative predictive powers. Arch Clin Neuropsychol 2008, 23:603-612.
9. Fink G., Sumner B., Rosie R., Wilson H., McQueen J. Androgen actions on central serotonin neurotransmission: relevance for mood, mental state and memory. Behav Brain Res 1999, 105:53-68.
10. Friston K.J., Grasby P.M., Frith C.D., Bench C.J., Dolan R.J., Cowen P.J., et al. The neurotransmitter basis of cognition: psychopharmacological activation studies using positron emission tomography. Ciba Found Symp 1991, 163:76-87. discussion 87-92.
11. George T.P., Vessicchio J.C., Termine A., Sahady D.M., Head C.A., Pepper W.T., et al. Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharmacology 2002, 26(1):75-85.
12. Goldberg T.E., Gold J.M., Torrey E.F., Weinberger D.R. Lack of sex differences in the neuropsychological performance of patients with schizophrenia. Am J Psychiatry 1995, 152:883-888.
13. Goldstein J.M., Seidman L.J., Goodman J.M., Koren D., Lee H., Weintraub S., et al. Are there sex differences in neuropsychological functions among patients with schizophrenia?. Am J Psychiatry 1998, 155:1358-1364.
14. Goldstein J.M., Seidman L.J., O'Brien L.M., Horton N.J., Kennedy D.N., Makris N., et al. Impact of normal sexual dimorphisms on sex differences in structural brain abnormalities in schizophrenia assessed by magnetic resonance imaging. Arch Gen Psychiatry 2002, 59:154-164.
15. Grigoriadis S., Seeman M.V. The role of estrogen in schizophrenia: implications for schizophrenia practice guidelines for women. Can J Psychiatry 2002, 47:437-442.
16. Gur R.C., Alsop D., Glahn D., Petty R., Swanson C.L., Maldjian J.A., et al. An fMRI study of sex differences in regional activation to a verbal and a spatial task. Brain Lang 2000, 74:157-170.
17. Gur R.E., Calkins M.E., Gur R.C., Horan W.P., Nuechterlein K.H., Seidman L.J., et al. The consortium on the genetics of schizophrenia: neurocognitive endophenotypes. Schizophr Bull 2007, 33:49-68.
18. Hafner H., Behrens S., De Vry J., Gattaz W.F. An animal model for the effects of estradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia. Psychiatry Res 1991, 38:125-134.
19. Hahn C., Hahn E., Dettling M., Güntürkün O., Ta T.M., Neuhaus A.H. Effects of smoking history on selective attention in schizophrenia. Neuropharmacology 2012, 62(4):1897-1902.
20. Halari R., Mehrotra R., Sharma T., Ng V., Kumari V. Cognitive impairment but preservation of sexual dimorphism in cognitive abilities in chronic schizophrenia. Psychiatry Res 2006, 141:129-139.
21. Hoff A.L., Wieneke M., Faustman W.O., Horon R., Sakuma M., Blankfeld H., et al. Sex differences in neuropsychological functioning of first-episode and chronically ill schizophrenic patients. Am J Psychiatry 1998, 155:1437-1439.
22. Hughes C., Kumari V., Soni W., Das M., Binneman B., Drozd S., et al. Longitudinal study of symptoms and cognitive function in chronic schizophrenia. Schizophr Res 2003, 59:137-146.
23. Karakaya S., Kipp M., Beyer C. Oestrogen regulates the expression and function of dopamine transporters in astrocytes of the nigrostriatal system. J Neuroendocrinol 2007, 19:682-690.
24. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13:261-276.
25. Lewine R.R., Walker E.F., Shurett R., Caudle J., Haden C. Sex differences in neuropsychological functioning among schizophrenic patients. Am J Psychiatry 1996, 153:1178-1184.
26. McEwen B.S., Woolley C.S. Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain. Exp Gerontol 1994, 29:431-436.
27. Newell K.A., Zavitsanou K., Jew S.K., Huang X.-F. Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:225-233.
28. Phillips K., Silverman I. Differences in the relationship of menstrual cycle phase to spatial performance on two- and three-dimensional tasks. Horm Behav 1997, 32:167-175.
29. Ragland J.D., Gur R.E., Klimas B.C., McGrady N., Gur R.C. Neuropsychological laterality indices of schizophrenia: interactions with gender. Schizophr Bull 1999, 25:79-89.
30. Rubin L.H., Haas G.L., Keshavan M.S., Sweeney J.A., Maki P.M. Sex difference in cognitive response to antipsychotic treatment in first episode schizophrenia. Neuropsychopharmacology 2008, 33:290-297.
31. Seidman L.J., Goldstein J.M., Goodman J.M., Koren D., Turner W.M., Faraone S.V., et al. Sex differences in olfactory identification and Wisconsin Card Sorting performance in schizophrenia: relationship to attention and verbal ability. Biol Psychiatry 1997, 42:104-115.
32. Smith R.C., Singh A., Infante M., Khandat A., Kloos A. Effects of cigarette smoking and nicotine nasal spray on psychiatricsymptoms and cognition in schizophrenia. Neuropsychopharmacology 2002, 27(3):479-497.
33. Sota T.L., Heinrichs R.W. Sex differences in verbal memory in schizophrenia patients treated with "typical" neuroleptics. Schizophr Res 2003, 62:175-182.
34. Stefansson H., Ophoff R.A., Steinberg S., Andreassen O.A., Cichon S., Rujescu D., et al. Common variants conferring risk of schizophrenia. Nature 2009, 460:744-747.
35. Stip E. Cognition, schizophrenia and the effect of antipsychotics. Encéphale 2006, 32:341-350.
36. Sumiyoshi T., Stockmeier C., Overholser J., Dilley G., Meltzer H. Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia. Eur Neuropsychopharmacol 1996, 6:212-212.
37. Szeszko P.R., Vogel J., Ashtari M., Malhotra A.K., Bates J., Kane J.M., et al. Sex differences in frontal lobe white matter microstructure: a DTI study. Neuroreport 2003, 14:2469-2473.
38. Terry A.V., Mahadik S.P. Time-dependent cognitive deficits associated with first and second generation antipsychotics: cholinergic dysregulation as a potential mechanism. J Pharmacol Exp Ther 2007, 320:961-968.
39. Walker E.F., Lewine R.R. Sampling biases in studies of gender and schizophrenia. Schizophr Bull 1993, 19:1-7. discussion 9-14.
40. Walters J.T.R., Corvin A., Owen M.J., Williams H., Dragovic M., Quinn E.M., et al. Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia. Arch Gen Psychiatry 2010, 67:692-700.
41. Wegesin D.J., Stern Y. Effects of hormone replacement therapy and aging on cognition: evidence for executive dysfunction. Aging Neuropsychol Cogn 2007, 14:301-328.
42. Wisner K.M., Elvevag B., Gold J.M., Weinberger D.R., Dickinson D. A closer look at siblings of patients with schizophrenia: the association of depression history and sex with cognitive phenotypes. Schizophr Res 2011, 126:164-173.
43. Zavitsanou K., Katsifis A., Mattner F., Huang X.-F. Investigation of m1/m4 muscarinic receptors in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression disorder. Neuropsychopharmacology 2004, 29:619-625.
44. Zhang B.H., Tan Y.L., Zhang W.F., Wang Z.R., Yang G.G., Shi C., et al. Repeatable battery for the assessment of neuropsychological status (RBANS) as a screening test in Chinese: reliability and validity. Chin Ment Health J 2009, 28:865-869.
45. Zhang X.Y., Chen D.C., Xiu M.H., Haile C.N., Sun H.Q., Lu L., et al. Cigarette smoking and cognitive function in Chinese male schizophrenia: a case-control study. PLoS One 2012, 7:e36563.